Product

PEGylated recombinant human interferon alpha-2b

Aliases

Nucleotide analogues, PEGylated recombinant human interferon alpha-2b injection

1 clinical trial

2 indications

Indication

Indication

Clinical trial

A Multicenter, Prospective Cohort Study: Efficacy of NA Combined With PEG-IFN-α2b Continuous Versus Pulsed Therapy for 96 Weeks in Patients With Chronic Hepatitis B.

Status: Recruiting, Estimated PCD: 2027-06-01